Vivalytic, the fully automated, cartridge-based platform from Randox
Randox is committed to developing state-of-the-art technology including chemistry, immunoassay, molecular and POC platforms, in addition to complete quality control solutions and high-quality first- and third-party reagents.
Developing the gold standard in testing, Randox patented Biochip Technology presents unique testing capabilities by enabling a multiplex testing method. This has found application in hospitals, clinical research and molecular laboratories, food testing, forensic toxicology, veterinary laboratories and POCT. Randox adapts quickly to meet market demands and currently offers a diverse range of testing solutions for COVID-19.
Utilising its Biochip Technology capable of conducting multiple tests simultaneously, the Randox Biochip has two tests for COVID-19, one specific and one confirmatory, both run on the all-in-one
molecular solution, Vivalytic, a universal, fully automated, cartridge-based platform.
[email protected]
www.randox.com
Other News
Featured Supplier
Often, better healthcare is less about pioneering breakthroughs or techniques and more about finding ways to better use existing technology to improve outcomes. And that’s what Una Health is all about: taking an innovative approach to diagnostics to challenge traditional pathways and improve patient outcomes.
We specialise in Pathology and...
Upcoming Events
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
